A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting (Q34331430)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

Björn Stollenwerk

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Sonja Zindel

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

Stephanie Stock

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

Dirk Müller

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

publication date

9 July 2012

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

BMC Health Services Research

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

192

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Newer anticoagulants in 2009.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--has no clinically relevant interaction with naproxen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Low-molecular-weight heparin: is small beautiful?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

6 July 2018

Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty

1 reference

https://api.crossref.org/works/10.1186/1472-6963-12-192

21 January 2018

Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery

1 reference

https://api.crossref.org/works/10.1186/1472-6963-12-192

21 January 2018

Estimated annual costs of prophylaxis and treatment of venous thromboembolic events associated with major orthopedic surgery in France

1 reference

https://api.crossref.org/works/10.1186/1472-6963-12-192

21 January 2018

A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting

1 reference

https://api.crossref.org/works/10.1186/1472-6963-12-192

21 January 2018

Cost-effectiveness of rivaroxaban versus enoxaparin for the prevention of postsurgical venous thromboembolism in Canada

1 reference

https://api.crossref.org/works/10.1186/1472-6963-12-192

21 January 2018

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

27 October 2018

A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

27 October 2018

Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551680

27 October 2018

Comparing methodologies for the cost estimation of hospital services

1 reference

https://pubmed.ncbi.nlm.nih.gov/22776616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital: summary of the NICE guideline

1 reference

https://pubmed.ncbi.nlm.nih.gov/22776616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uncertainty assessment of input parameters for economic evaluation: Gauss's error propagation, an alternative to established methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/22776616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22776616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22776616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of post-thrombotic syndrome in patients with previous pulmonary embolism. A retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22776616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost accounting to determine prices: how well do prices reflect costs in the German DRG-system?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22776616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1472-6963-12-192

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22776616 AND SRC:MED&resulttype=core&format=json

7 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34331430&oldid=2196513565"